Correspondence
Favorable outcome after COVID-19 infection in a multiple sclerosis patient initiated on ocrelizumab during the pandemic

https://doi.org/10.1016/j.msard.2020.102222Get rights and content

Keywords

COVID-19
Multiple sclerosis
Ocrelizumab

Cited by (0)

View Abstract